All Articles

Ovarian cancer survivors frequently use adaptive and problem-focused coping strategies. During the COVID-19 pandemic, virtual technology has played a key role in shaping and determining these strategies.

Oral treatments for ovarian cancer can be taken at home, in a sequestered environment that may minimize undue risks for patients. Results from a randomized phase 3 study suggest oral PARP inhibitor therapy has improved efficacy when compared with intravenous chemotherapy.

Telemedicine may play a critical role by creating pathways for overcoming obstacles to healthcare access, particularly for breast cancer reconstruction.

Joining an LNN is a great way to connect with other navigators while enhancing your ability to improve outcomes and the survivorship experience for patients. Here’s how.

Local Navigator Networks are enhancing the professional growth of navigators – here’s what you should know about this fresh approach to networking!

Leaders of the AONN+ Local Navigator Networks share lessons in implementing and sustaining their programs.

Experts reveal the key components to building and sustaining effective Local Navigator Networks.

Treatment with dabrafenib and trametinib produced similar benefits in pretreated and treatment-naïve patients.

US Food and Drug Administration–approved capmatinib is an effective second-line treatment for patients with MET exon 14–mutated NSCLC.